Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 102

Sort by

Sort Order Select

Journal Articles

Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria

Christoph R. Kimmich, Tobias Terzer, Axel Benner, Tobias Dittrich, Kaya Veelken, Alexander Carpinteiro, Timon Hansen, Hartmut Goldschmidt, Anja Seckinger, Dirk Hose, Anna Jauch, Stefan Wörner, Jörg Beimler, Carsten Müller-Tidow, Ute Hegenbart, Stefan O. Schönland

Blood (2020) 135 (18): 1517–1530.

https://doi.org/10.1182/blood.2019003633

Published: 2020

Includes: Supplemental data

Journal Articles

Thrombin Generation in Nephrotic Syndrome Is Dependent on Remission Status and Hypercholestrolemia

Bryce Kerlin, Amanda P. Waller, PhD, Jonathan P. Troost, PhD, Samir Parikh, MD, William E. Smoyer, MD, Matthias Kretzler, MD

Blood (2019) 134 (Supplement_1): 2422.

https://doi.org/10.1182/blood-2019-128680

Published: 2019

Journal Articles

Risk Factors for Pediatric Cerebral Sinovenous Thrombosis: A Case-Control Study with Pediatric Neuroradiologist Case Validation

Austin R Sellers, MS, Anh Thy Nguyen, MSPH, Marisol Betensky, MDMPH, Katie Mills, DNP, APRN, Neil A Goldenberg, MD PhD, Nir Shimony, MD

Blood (2019) 134 (Supplement_1): 2427.

https://doi.org/10.1182/blood-2019-130906

Published: 2019

Journal Articles

Kidney Iron Deposition By R2* Is Associated with Hemolysis and Urinary Iron

Christopher C Denton, MD, Jon A Detterich, MD, Thomas Coates, MD, John C Wood, MD PhD

Blood (2019) 134 (Supplement_1): 3537.

https://doi.org/10.1182/blood-2019-131659

Published: 2019

Journal Articles

Diagnostic Delay and Characterization of the Clinical Prodrome in AL Amyloidosis: Data from 1,313 US Commercially Insured Patients between 2006-2018

Laura L Hester, PhD MSc, Dina M Gifkins, PhD MPH, Kevin M Bellew, MS, MA, Jessica Vermeulen, MD PhD, Jordan M Schecter, MD, Frank J DeFalco, Brendan M Weiss, MD

Blood (2019) 134 (Supplement_1): 5517.

https://doi.org/10.1182/blood-2019-124250

Published: 2019

Journal Articles

Daratumumab (DARA) Maintenance Therapy Improves Depth of Response and Results in Durable Progression-Free Survival (PFS) Following Dara Plus Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) Induction Therapy in Multiple Myeloma (MM): Update of the Lyra Study

Robert M. Rifkin, MD, Jason M. Melear, MD, Edward Faber, DO, MS, William I. Bensinger, John M Burke, MD, Mohit Narang, MD, Don Stevens, MD, Sriya Gunawardena, Yana Lutska, PharmD, Keqin Qi, PhD, Jon Ukropec, PhD, Ming Qi, MD PhD, Thomas S. Lin, MD PhD, Habte A Yimer, MD

Blood (2019) 134 (Supplement_1): 863.

https://doi.org/10.1182/blood-2019-122497

Published: 2019

Journal Articles

Primary Treatment of Light Chain (AL) Amyloidosis with Bortezomib, Lenalidomide and Dexamethasone (VRD)

Blood (2018) 132 (Supplement 1): 3248.

https://doi.org/10.1182/blood-2018-99-111608

Published: 2018

Journal Articles

The Hypofibrinolytic Defect of Nephrotic Syndrome Is Directly Proportional to Fibrin Network Density

Amanda P. Waller, PhD, Katelyn J Wolfgang, Bryce A. Kerlin, MD

Blood (2018) 132 (Supplement 1): 1218.

https://doi.org/10.1182/blood-2018-99-119947

Published: 2018

Journal Articles

Epidemiological and Clinical Characteristics of Monoclonal Gammopathy of Renal Significance (MGRS) in South America

Camila Peña, MD, Gonzalo P Mendez, MD, Natalia Paola Schutz, MD, Eloisa Riva, MD, Ricardo Valjalo, MD, Hernán López-Vidal, MD, Alejandro Majlis, MD, Vivianne Lois, MD, Daniela Zamora, MD, Jose T Gonzalez, MD, Dorotea Beatriz Fantl, MD

Blood (2018) 132 (Supplement 1): 5856.

https://doi.org/10.1182/blood-2018-99-113198

Published: 2018

Journal Articles

Treatment Outcomes in Monoclonal Immunoglobulin Deposition Disease (MIDD): A Two Center Experience

Matthew J. Pianko, MD, Timothy Tiutan, MD, Jessica Flynn, BS, Sean M Devlin, PhD, Insara Jaffer-Sathick, MBBS, Adriana C. Rossi, MD MSc, Steven P. Salvatore, MD, Heather J. Landau, MD, Nikoletta Lendvai, MD PhD, Eric L. Smith, MD PhD, Neha Korde, MD, Sham Mailankody, MBBS, Alexander M. Lesokhin, MD, Malin Hultcrantz, MD PhD, David J. Chung, MD PhD, Sergio Giralt, MD, Ola Landgren, MD PhD, Hani Hassoun, MD

Blood (2018) 132 (Supplement 1): 5591.

https://doi.org/10.1182/blood-2018-99-112110

Published: 2018

Journal Articles

Prophylactic Infusion of Multi-Antigen Specific T-Cell Products to Prevent Complications after T Cell Depleted Allogeneic Stem Cell Transplantation — a Phase I/II Study

Marthe C.J. Roex, MD, Peter van Balen, MD, Lothar Germeroth, PhD, Lois Hageman, Esther van Egmond, Sabrina A.J. Veld, Conny Hoogstraten, Ellis van Liempt, PhD, Jaap J. Zwaginga, MD PhD, Liesbeth C. de Wreede, PhD, Hermann Einsele, MD PhD, Hendrik Veelken, MD PhD, Constantijn J.M. Halkes, MD, Inge Jedema, PhD, J.H. Frederik Falkenburg, MD PhD

Blood (2018) 132 (Supplement 1): 119.

https://doi.org/10.1182/blood-2018-99-111749

Published: 2018

Journal Articles

Immune Tolerance Induction for FIX Inhibitors Using Combined B and T Cell Immune Modulation Therapy in Severe Hemophilia B

Yasmina L. Abajas, MD, Paul Edward Monahan, MD, Brenda Nielsen, RN, Pia Petrini, MD, Susanna Ranta, MD PhD, Geoffrey A. Allen, MD, Silvia Horneff, MD, Annika Martensson, MD PhD, Johannes Oldenburg, MD PhD, Rolf Ljung, MD PhD Professor

Blood (2018) 132 (Supplement 1): 1193.

https://doi.org/10.1182/blood-2018-99-120141

Published: 2018

Journal Articles

Outcomes and Risk Factors Associated with Thrombosis Recurrence and Post-Thrombotic Syndrome in Children and Adolescents with May-Thurner Syndrome

Michael H. White, MD, Brandon M. Cramer, MD, Anne E. Gill, MD, C. Matthew Hawkins, MD, Kavita N. Patel, MD MS

Blood (2017) 130 (Supplement 1): 3417.

https://doi.org/10.1182/blood.V130.Suppl_1.3417.3417

Published: 2017

Journal Articles

Initial Results of KD025-208: A Phase 2a Open Label Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease

Aleksandr Lazaryan, MD PhD MPH, Stephanie J Lee, MD MPH, Amandeep Salhotra, MD, Madan Jagasia, MD MBBS, MS, James Essell, MD, Alexandra Zanin-Zhorov, PhD, Beth Mac Gillivray, MSc, Olivier Schueller, PhD, David Eiznhamer, PhD, Bruce Blazar, MD, John L. Ryan, MD PhD

Blood (2017) 130 (Supplement 1): 3256.

https://doi.org/10.1182/blood.V130.Suppl_1.3256.3256

Published: 2017

Journal Articles

Defective Function of KCa3.1 Channels in Lysosomal Storage Disorders

Pilar Giraldo, PhD, Jorge J Cebolla, fellow, Pilar Irun, PhD, Laura Lopez de Frutos, MSc, Marcio Andrade-Campos, PhD, Ralf Köhler, PhD

Blood (2017) 130 (Supplement 1): 3562.

https://doi.org/10.1182/blood.V130.Suppl_1.3562.3562

Published: 2017

Journal Articles

A Case of Immunotactoid Glomerulopathy (ITG) Associated with Monoclonal B-Cell Lymphocytosis (MBL) with Chronic Lymphocytic Leukemia (CLL) Phenotype Treated with Obinutuzumab

Nino Aleksidze, MD, Michael B Stokes, MD, Alan P Skarbnik, MD

Blood (2017) 130 (Supplement 1): 5324.

https://doi.org/10.1182/blood.V130.Suppl_1.5324.5324

Published: 2017

Journal Articles

The Hypofibrinolytic Defect of Nephrotic Syndrome Is Directly Proportional to Disease Severity

Amanda P. Waller, PhD, Katelyn J Wolfgang, Alisa S Wolberg, PhD, Bryce A. Kerlin, MD

Blood (2017) 130 (Supplement 1): 1072.

https://doi.org/10.1182/blood.V130.Suppl_1.1072.1072

Published: 2017

Journal Articles

Microcytic Anemia and Celiac Disease Preceding Pulmonary Symptoms in Lane-Hamilton Syndrome

Robert Szulawski, DO, Catherine D Quinn, MD, Eric Safyan, MD

Blood (2017) 130 (Supplement 1): 4753.

https://doi.org/10.1182/blood.V130.Suppl_1.4753.4753

Published: 2017

Journal Articles

Dasatinib Induced Reversible Nephrotic Range Proteinuria Occurs More Frequently Compared to Other Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia

Ali Alahmari, MD, Jeffrey H. Lipton, MD PhD, Dennis Kim, MD

Blood (2017) 130 (Supplement 1): 2880.

https://doi.org/10.1182/blood.V130.Suppl_1.2880.2880

Published: 2017

Journal Articles

Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy–associated C3 glomerulopathy

Sophie Chauvet, Véronique Frémeaux-Bacchi, Florent Petitprez, Alexandre Karras, Laurent Daniel, Stéphane Burtey, Gabriel Choukroun, Yahsou Delmas, Dominique Guerrot, Arnaud François, Moglie Le Quintrec, Vincent Javaugue, David Ribes, Laurence Vrigneaud, Bertrand Arnulf, Jean Michel Goujon, Pierre Ronco, Guy Touchard, Frank Bridoux

Blood (2017) 129 (11): 1437–1447.

https://doi.org/10.1182/blood-2016-08-737163

Published: 2017

Includes: Supplemental data

NARROW

Daratumumab for systemic AL amyloidosis: prognostic factors and adverse outcome with nephrotic-range albuminuria

Thrombin Generation in Nephrotic Syndrome Is Dependent on Remission Status and Hypercholestrolemia

Risk Factors for Pediatric Cerebral Sinovenous Thrombosis: A Case-Control Study with Pediatric Neuroradiologist Case Validation

Kidney Iron Deposition By R2* Is Associated with Hemolysis and Urinary Iron

Diagnostic Delay and Characterization of the Clinical Prodrome in AL Amyloidosis: Data from 1,313 US Commercially Insured Patients between 2006-2018

Daratumumab (DARA) Maintenance Therapy Improves Depth of Response and Results in Durable Progression-Free Survival (PFS) Following Dara Plus Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) Induction Therapy in Multiple Myeloma (MM): Update of the Lyra Study

Primary Treatment of Light Chain (AL) Amyloidosis with Bortezomib, Lenalidomide and Dexamethasone (VRD)

The Hypofibrinolytic Defect of Nephrotic Syndrome Is Directly Proportional to Fibrin Network Density

Epidemiological and Clinical Characteristics of Monoclonal Gammopathy of Renal Significance (MGRS) in South America

Treatment Outcomes in Monoclonal Immunoglobulin Deposition Disease (MIDD): A Two Center Experience

Prophylactic Infusion of Multi-Antigen Specific T-Cell Products to Prevent Complications after T Cell Depleted Allogeneic Stem Cell Transplantation — a Phase I/II Study

Immune Tolerance Induction for FIX Inhibitors Using Combined B and T Cell Immune Modulation Therapy in Severe Hemophilia B

Outcomes and Risk Factors Associated with Thrombosis Recurrence and Post-Thrombotic Syndrome in Children and Adolescents with May-Thurner Syndrome

Initial Results of KD025-208: A Phase 2a Open Label Trial of KD025 for Steroid-Dependent Chronic Graft Versus Host Disease

Defective Function of KCa3.1 Channels in Lysosomal Storage Disorders

A Case of Immunotactoid Glomerulopathy (ITG) Associated with Monoclonal B-Cell Lymphocytosis (MBL) with Chronic Lymphocytic Leukemia (CLL) Phenotype Treated with Obinutuzumab

The Hypofibrinolytic Defect of Nephrotic Syndrome Is Directly Proportional to Disease Severity

Microcytic Anemia and Celiac Disease Preceding Pulmonary Symptoms in Lane-Hamilton Syndrome

Dasatinib Induced Reversible Nephrotic Range Proteinuria Occurs More Frequently Compared to Other Tyrosine Kinase Inhibitors in the Treatment of Chronic Myeloid Leukemia

Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy–associated C3 glomerulopathy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only